4//SEC Filing
Xie Jian 4
Accession 0000950170-25-099792
CIK 0001674930other
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 6:04 PM ET
Size
6.1 KB
Accession
0000950170-25-099792
Insider Transaction Report
Form 4
Xie Jian
President and COO
Transactions
- Tax Payment
Common Stock
2025-07-26$18.37/sh−4,352$79,946→ 367,144 total
Holdings
- 220,816(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022.
- [F2]Securities held by The Hsieh Family Dynasty Trust, dated January 27, 2010 (the "Trust"). Mr. Xie serves on the investment committee of the Trust. Mr. Xie disclaims any beneficial interest except with respect to any pecuniary interest therein.
Documents
Issuer
Fulgent Genetics, Inc.
CIK 0001674930
Entity typeother
Related Parties
1- filerCIK 0001819718
Filing Metadata
- Form type
- 4
- Filed
- Jul 28, 8:00 PM ET
- Accepted
- Jul 29, 6:04 PM ET
- Size
- 6.1 KB